carvedilol has been researched along with malondialdehyde in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.06) | 18.2507 |
| 2000's | 10 (30.30) | 29.6817 |
| 2010's | 17 (51.52) | 24.3611 |
| 2020's | 4 (12.12) | 2.80 |
| Authors | Studies |
|---|---|
| Gabriels, M; Vamecq, J; Van den Branden, C; Vanden Houte, K; Verbeelen, D | 1 |
| Bartosíková, L; Drápelová, L; Husek, K; Kuchtícková, S; Necas, J; Pavlícek, V | 1 |
| Kumar, KV; Naidu, MU; Ratnakar, KS; Shifow, AA | 1 |
| Shliakhto, EV; Sitnikova, MIu | 1 |
| Aref'eva, TI; Ataullakhanova, DM; Chazova, IE; Irodova, NL; Konovalova, GG; Krasnikova, TL; Lankin, VZ; Lazutkina, VK; Masenko, VP; Orlova, IaA; Sokolov, SF | 1 |
| Alcaino, H; Castro, P; Chiong, M; Copaja, M; Corbalan, R; Díaz-Araya, G; Greig, D; Lavandero, S; Pérez, O; Valenzuela, R; Vukasovic, JL | 1 |
| Huang, H; Pan, XH; Qian, LB; Shan, J; Wang, HP | 1 |
| Dohi, Y; Kimura, G; Kojima, M; Sato, K; Ueda, R | 1 |
| Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y | 1 |
| Catena, C; Donnini, D; Milocco, C; Moretti, M; Sechi, LA; Soardo, G | 1 |
| Bravo, R; Castro, PF; Chiong, M; del Campo, A; Díaz-Araya, G; Greig, D; Lavandero, S; Mellado, R; Moraga, F; Rodriguez, A; Roldán, J; Sanhueza, C; Troncoso, R; Valenzuela, R; Vukasovic, JL | 1 |
| Kumar, A; Prakash, AK | 1 |
| Chen, P; Ge, LS; Guan, XQ; Li, YC; Lin, JF; Tang, JF; Yang, PL | 1 |
| Barbosa, F; Curti, C; Martins, NM; Rodrigues, JL; Rodrigues, MA; Santos, AC; Santos, NA | 1 |
| Goel, A; Goel, R; Kumar, Y | 1 |
| Atilgan, D; Erdemir, F; Firat, F; Koseoglu, RD; Parlaktas, BS; Saylan, O; Yasar, A | 1 |
| Fernandes, AA; Fiorim, J; Forechi, L; Lima, FL; Pavan, BM; Potratz, FF; Ribeiro, RF; Stefanon, I; Vassallo, DV | 1 |
| Fu, Q; Huang, Y; Jia, C; Li, B; Liang, F; Liu, D | 1 |
| Abd Elhameed, AG; Abu-Elsaad, NM; El-Karef, A; Ibrahim, TM | 1 |
| Akgüllü, Ç; Boyacıoğlu, M; Eryılmaz, U; Güngör, H; Hekim, T; Karul, A; Meteoğlu, İ; Onbaşılı, OA | 1 |
| Afrin, MR; Arumugam, S; Harima, M; Karuppagounder, V; Miyashita, S; Nakamura, M; Nomoto, M; Pitchaimani, V; Sreedhar, R; Ueno, K; Watanabe, K; Wen, J | 1 |
| Abdel Kawy, HS | 1 |
| Carvalho, AF; Cavalcante, LM; de Araújo, MM; de Góis Queiroz, AI; de Lucena, DF; de Souza, GC; Gomes, JA; Macêdo, D; Machado, Mde J; Monte, AS; Quevedo, J | 1 |
| Abuohashish, HM; Ahmed, MM; Al-Hosaini, KA; Al-Rejaie, SS; Fatani, AJ; Parmar, MY | 1 |
| Araújo Júnior, RF; Brito, GA; de Araújo, AA; Garcia, VB; Guedes, PM; Leitão, RF; Miguel, Ede C | 1 |
| Arıcı, A; Bütün, İ; Irmak Sapmaz, H; Kunt İşgüder, Ç; Nursal, AF; Özsoy, AZ; Taş, U; Uysal, M; Yılmaz Doğru, H | 1 |
| Geng, J; Liu, Q; Lu, D; Shan, Q; Wang, K; Wang, S; Zhang, B; Zhang, Q | 1 |
| Abbas, NAT; Abdel Aal, SM; Mousa, HSE | 1 |
| Abdel-Kawy, HS | 1 |
| Bayoumi, AMA; El-Hussieny, M; Refaie, MMM; Shehata, S | 1 |
| Ahmed, MAE; El Morsy, EM | 1 |
| Ibrahim, IAAE; Mahmoud, AAA; Mahmoud, MF; Rezk, AM | 1 |
| Amirshahrokhi, K; Zohouri, A | 1 |
3 trial(s) available for carvedilol and malondialdehyde
| Article | Year |
|---|---|
[Endothelial protection in patients with apparent cardiac failure in long-term therapy by carvedilol].
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelium, Vascular; Heart Failure; Humans; Interleukin-8; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Myocardial Ischemia; Propanolamines; Time Factors; Treatment Outcome; Triglycerides; Uric Acid | 2003 |
Carvedilol reduces elevated B-type natriuretic peptide in dialyzed patients without heart failure: cardioprotective effect of the beta-blocker.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Biomarkers; Blood Flow Velocity; Blood Pressure; C-Reactive Protein; Carbazoles; Carvedilol; Female; Heart Failure; Heart Rate; Humans; Interleukin-6; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Renal Dialysis; Research Design; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2007 |
Gln(27)-->Glubeta(2)-adrenergic receptor polymorphism in heart failure patients: differential clinical and oxidative response to carvedilol.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Chronic Disease; Down-Regulation; Female; Heart Failure; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pharmacogenetics; Polymorphism, Genetic; Propanolamines; Receptors, Adrenergic, beta-2; Ventricular Function, Left | 2009 |
30 other study(ies) available for carvedilol and malondialdehyde
| Article | Year |
|---|---|
Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.
Topics: Adrenergic beta-Antagonists; Aldehydes; Animals; Antioxidants; Blood Pressure; Carbazoles; Carvedilol; Free Radical Scavengers; Glomerulosclerosis, Focal Segmental; Hydrogen Peroxide; Kidney Cortex; Kidney Failure, Chronic; Lipid Peroxidation; Male; Malondialdehyde; Nephrectomy; Propanolamines; Propranolol; Rats; Rats, Wistar | 1997 |
[The effects of Carvedilol, a beta-blocker, in experimental ischemia-reperfusion kidney injury].
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Kidney; Male; Malondialdehyde; Propanolamines; Rats; Rats, Wistar; Reperfusion Injury | 1997 |
Carvedilol: a beta blocker with antioxidant property protects against gentamicin-induced nephrotoxicity in rats.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Carbazoles; Carvedilol; Gentamicins; Kidney; Lipid Peroxidation; Male; Malondialdehyde; Propanolamines; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Urea | 2000 |
[Primary pulmonary hypertension: activation of sympathico-adrenal system and free radical oxidation. Positive effects of carvedilol therapy].
Topics: Adrenergic Agents; Adult; Aged; Antihypertensive Agents; Carbazoles; Carvedilol; Catalase; Female; Free Radicals; Heart Failure; Humans; Hypertension, Pulmonary; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Oxidoreductases; Propanolamines; Sympathetic Nervous System | 2005 |
Effects of carvedilol on oxidative stress and chronotropic response to exercise in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Glutathione Peroxidase; Heart Failure; Heart Function Tests; Heart Rate; Humans; Linear Models; Male; Malondialdehyde; Middle Aged; Norepinephrine; Oxidative Stress; Probability; Propanolamines; Prospective Studies; Radionuclide Ventriculography; Severity of Illness Index; Stroke Volume; Superoxide Dismutase | 2005 |
Carvedilol protected diabetic rat hearts via reducing oxidative stress.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Carbazoles; Carvedilol; Diabetes Mellitus, Experimental; Heart; Male; Malondialdehyde; Myocytes, Cardiac; Oxidative Stress; Propanolamines; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Streptozocin; Systole | 2006 |
Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Carbazoles; Cardiotonic Agents; Carvedilol; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; Interleukins; Male; Malondialdehyde; Metoprolol; Mice; Mice, Inbred BALB C; Myocarditis; Propanolamines; Quinazolines; Superoxide Dismutase; Up-Regulation | 2008 |
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells.
Topics: Antihypertensive Agents; Captopril; Carbazoles; Carvedilol; Cells, Cultured; Dihydropyridines; Dose-Response Relationship, Drug; Endothelial Cells; Ethanol; Humans; Malondialdehyde; Nitric Oxide; Oxidative Stress; Propanolamines | 2008 |
Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin induced model of dementia in rats.
Topics: Acetylcholinesterase; Animals; Antioxidants; Behavior, Animal; Brain; Carbazoles; Carvedilol; Catalase; Dementia; Drug Administration Routes; Drug Administration Schedule; Glutathione; Male; Malondialdehyde; Maze Learning; Models, Animal; Nitrites; Oxidative Stress; Propanolamines; Rats; Rats, Wistar; Streptozocin; Superoxide Dismutase | 2009 |
Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction.
Topics: Adrenergic Antagonists; Aldehydes; Animals; Body Weight; Carbazoles; Carvedilol; Electrocardiography; Enterovirus; Glutathione Peroxidase; Heart; Hemodynamics; Male; Malondialdehyde; Metoprolol; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Organ Size; Oxidative Stress; Propanolamines; Superoxide Dismutase; Survival Rate; Time Factors; Viral Load | 2010 |
Carvedilol protects against cisplatin-induced oxidative stress, redox state unbalance and apoptosis in rat kidney mitochondria.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Blood Urea Nitrogen; Carbazoles; Carvedilol; Cisplatin; Creatinine; Drug Interactions; Humans; Kidney Diseases; Malondialdehyde; Mitochondria; Oxidation-Reduction; Oxidative Stress; Propanolamines; Rats; Rats, Wistar; Statistics, Nonparametric | 2011 |
Influence of carvedilol on anticonvulsant effect of gabapentin.
Topics: Amines; Analysis of Variance; Animals; Anticonvulsants; Brain; Carbazoles; Carvedilol; Convulsants; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Electroshock; Exploratory Behavior; Gabapentin; gamma-Aminobutyric Acid; Glutathione; Lipid Peroxidation; Male; Malondialdehyde; Memory; Mice; Motor Activity; Pentylenetetrazole; Propanolamines; Rotarod Performance Test; Seizures; Vasodilator Agents | 2011 |
The effect of carvedilol on serum and tissue oxidative stress parameters in partial ureteral obstruction induced rat model.
Topics: Animals; Carbazoles; Carvedilol; Disease Models, Animal; Drug Administration Schedule; Kidney; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Propanolamines; Protein Carbonylation; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase; Ureter; Ureteral Obstruction; Vasodilator Agents | 2013 |
Carvedilol prevents ovariectomy-induced myocardial contractile dysfunction in female rat.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Calcium; Carbazoles; Carvedilol; Female; Heart; Heart Diseases; Hemodynamics; Malondialdehyde; Myocardial Contraction; Myocardium; Organ Size; Ovariectomy; Peptidyl-Dipeptidase A; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Superoxides | 2013 |
Carvedilol promotes neurological function, reduces bone loss and attenuates cell damage after acute spinal cord injury in rats.
Topics: Animals; Apoptosis; Bone and Bones; Bone Density; Carbazoles; Carvedilol; Caspase 3; Fas Ligand Protein; fas Receptor; Female; Glutathione; Interleukin-1beta; Interleukin-6; Malondialdehyde; NF-kappa B; Osteoclasts; Osteoporosis; Oxidative Stress; Propanolamines; RANK Ligand; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord Injuries; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2015 |
Yogurt Containing the Probacteria Lactobacillus acidophilus Combined with Natural Antioxidants Mitigates Doxorubicin-Induced Cardiomyopathy in Rats.
Topics: Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Camellia sinensis; Carbazoles; Cardiomyopathies; Cardiotonic Agents; Carvedilol; Cholesterol; Cytokines; Daucus carota; Doxorubicin; Functional Food; Heart; Lactobacillus acidophilus; Lipid Peroxidation; Male; Malondialdehyde; Myocardium; Oxidative Stress; Probiotics; Propanolamines; Rats, Sprague-Dawley; Yogurt | 2015 |
The usefulness of carvedilol and nebivolol in preventing contrast nephropathy in rats.
Topics: Animals; Antihypertensive Agents; Antioxidants; Carbazoles; Carvedilol; Contrast Media; Diatrizoate; Disease Models, Animal; Kidney; Kidney Diseases; Malondialdehyde; Nebivolol; Oxidative Stress; Propanolamines; Protective Agents; Rats; Rats, Wistar; Superoxide Dismutase; Vasoconstriction | 2015 |
Effect of carvedilol against myocardial injury due to ischemia-reperfusion of the brain in rats.
Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Blood Pressure; Brain; Carbazoles; Carvedilol; Heart; Heart Rate; Male; Malondialdehyde; Myocardium; p38 Mitogen-Activated Protein Kinases; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Reperfusion Injury | 2015 |
Low-dose carvedilol protects against acute septic renal injury in rats during the early and late phases.
Topics: Acute Kidney Injury; Animals; Carbazoles; Carvedilol; Disease Models, Animal; Glutathione; Inflammation; Interleukin-6; Kidney; Male; Malondialdehyde; Mitochondria; NADPH Dehydrogenase; Propanolamines; Protective Agents; Rats; Rats, Wistar; Sepsis; Tumor Necrosis Factor-alpha | 2015 |
Preclinical Evidences for an Antimanic Effect of Carvedilol.
Topics: Adrenergic beta-Antagonists; Animals; Antimanic Agents; Bipolar Disorder; Brain; Brain-Derived Neurotrophic Factor; Carbazoles; Carvedilol; Glutathione; Hippocampus; Lipid Peroxidation; Lisdexamfetamine Dimesylate; Male; Malondialdehyde; Motor Activity; Propanolamines; Rats; Rats, Wistar; Social Isolation; Valproic Acid | 2015 |
Carvedilol attenuates inflammatory biomarkers and oxidative stress in a rat model of ulcerative colitis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Carbazoles; Carvedilol; Colitis, Ulcerative; Colon; Cytokines; Dinoprostone; Disease Models, Animal; DNA; Male; Malondialdehyde; Mucus; Nitric Oxide; Oxidative Stress; Propanolamines; Rats, Wistar; RNA; Sulfhydryl Compounds | 2015 |
Carvedilol Improves Inflammatory Response, Oxidative Stress and Fibrosis in the Alcohol-Induced Liver Injury in Rats by Regulating Kuppfer Cells and Hepatic Stellate Cells.
Topics: Animals; Biomarkers; Carbazoles; Carvedilol; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Ethanol; Gene Expression Regulation; Glutathione Peroxidase; Hepatic Stellate Cells; Immunohistochemistry; Kupffer Cells; Liver Cirrhosis; Male; Malondialdehyde; Oxidative Stress; Peroxidase; Propanolamines; Rats; RNA, Messenger; Superoxide Dismutase | 2016 |
Effects of carvedilol on an ischemia/reperfusion model: Biochemical, histopathological and immunohistochemical evaluation.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Apoptosis; bcl-2-Associated X Protein; Carbazoles; Carvedilol; Caspase 3; Disease Models, Animal; Female; Glutathione Peroxidase; Immunohistochemistry; Malondialdehyde; Ovary; Propanolamines; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Superoxide Dismutase; Torsion Abnormality | 2016 |
Renal Denervation Attenuates Multi-Organ Fibrosis and Improves Vascular Remodeling in Rats with Transverse Aortic Constriction Induced Cardiomyopathy.
Topics: Alanine Transaminase; Angiotensin II; Animals; Aorta; Blood Pressure; Carbazoles; Cardiomegaly; Cardiomyopathies; Carvedilol; Constriction; Cystatin C; Denervation; Fibrosis; Heart Rate; Kidney; Malondialdehyde; Natriuretic Peptide, Brain; Organ Specificity; Oxidative Stress; Peptide Fragments; Procollagen; Propanolamines; Rats, Sprague-Dawley; Superoxide Dismutase; Transforming Growth Factor beta1; Vascular Remodeling | 2016 |
Umbilical cord blood-mesenchymal stem cells and carvedilol reduce doxorubicin- induced cardiotoxicity: Possible role of insulin-like growth factor-1.
Topics: Animals; Carbazoles; Cardiotoxicity; Carvedilol; Doxorubicin; Fetal Blood; Humans; Insulin-Like Growth Factor I; Male; Malondialdehyde; Mesenchymal Stem Cells; Myocardium; Propanolamines; Rats; Superoxide Dismutase; Vascular Endothelial Growth Factor A | 2018 |
Effect of carvedilol versus propranolol on acute and chronic liver toxicity in rats.
Topics: Acetaminophen; Adrenergic beta-Antagonists; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Carbon Tetrachloride; Carvedilol; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Glutathione; Hepatic Stellate Cells; Liver; Liver Cirrhosis, Experimental; Male; Malondialdehyde; Oxidative Stress; Propranolol; Rats, Wistar; Tumor Necrosis Factor-alpha | 2021 |
Mechanisms mediating the cardioprotective effect of carvedilol in cadmium induced cardiotoxicity. Role of eNOS and HO1/Nrf2 pathway.
Topics: Animals; Cadmium; Cardiotonic Agents; Cardiotoxicity; Carvedilol; Heme Oxygenase (Decyclizing); Male; Malondialdehyde; Myocardium; NF-E2-Related Factor 2; Nitric Oxide Synthase Type III; Rats, Wistar; Signal Transduction | 2019 |
Carvedilol attenuates l-arginine induced acute pancreatitis in rats through modulation of oxidative stress and inflammatory mediators.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Arginine; Biomarkers; C-Reactive Protein; Carvedilol; Glutathione; Hydrolases; Interleukin-1beta; Male; Malondialdehyde; Oxidative Stress; Pancreatitis; Peroxidase; Rats; Tumor Necrosis Factor-alpha | 2020 |
Quercetin and lithium chloride potentiate the protective effects of carvedilol against renal ischemia-reperfusion injury in high-fructose, high-fat diet-fed Swiss albino mice independent of renal lipid signaling.
Topics: Animals; Apoptosis; Carvedilol; Cytoprotection; Diet, High-Fat; Drug Synergism; Fructose; Kidney; Lithium Chloride; Male; Malondialdehyde; Mice; Oxidative Stress; Quercetin; Reperfusion Injury; Signal Transduction | 2021 |
Carvedilol prevents pancreatic β-cell damage and the development of type 1 diabetes in mice by the inhibition of proinflammatory cytokines, NF-κB, COX-2, iNOS and oxidative stress.
Topics: Animals; Blood Glucose; Body Weight; Carvedilol; Cyclooxygenase 2; Cytokines; Diabetes Mellitus, Type 1; Glutathione; Inflammation; Insulin; Insulin-Secreting Cells; Male; Malondialdehyde; Mice; NF-kappa B p50 Subunit; Nitric Oxide Synthase Type II; Oxidative Stress; Pancreas | 2021 |